Botulinum toxin in the failure of high urinary diversion closure

Jayanthi, 1995, The effect of temporary cutaneous diversion on ultimate bladder function, J Urol, 154, 889, 10.1016/S0022-5347(01)67196-9 Podestá, 2000, Urodynamic findings in boys with posterior urethral valves after treatment with primary valve ablation or vesicostomy and delayed ablation, J Urol, 164, 139, 10.1016/S0022-5347(05)67480-0 Vastyan, 2005, Cutaneous vesicostomy revisited—the second 15years, Eur J Pediatr Surg, 15, 170, 10.1055/s-2005-837609 Dmochowski, 2007, Botulinum toxin A in the overactive bladder: current status and future directions, BJU Int, 99, 247, 10.1111/j.1464-410X.2007.06575.x Ghanem, 2005, Long-term followup of bilateral high (sober) urinary diversion in patients with posterior urethral valves and its effect on bladder function, J Urol, 173, 1721, 10.1097/01.ju.0000157326.62792.39 Podesta, 2001, Bladder functional outcome after delayed vesicostomy closure and antireflux surgery in young infants with ‘primary’ vesico-ureteric reflux, BJU Int, 87, 473, 10.1046/j.1464-410X.2001.00095.x Puri, 2002, Initial surgical treatment as a determinant of bladder dysfunction in posterior urethral valves, Pediatr Surg Int, 18, 438, 10.1007/s00383-002-0713-7 Kurzrock, 2009, Pediatric enterocystoplasty: long-term complications and controversies, World J Urol, 27, 69, 10.1007/s00345-008-0335-3 Apostolidis, 2005, Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity, J Urol, 174, 977, 10.1097/01.ju.0000169481.42259.54 Chavarria, 2002, Review of the use of botulinum toxin in urology, Arch Esp Urol, 55, 167 Riccabona, 2004, Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia, J Urol, 171, 845, 10.1097/01.ju.0000108892.35041.2d Mejia, 2005, Long-term botulinum toxin efficacy, safety, and immunogenicity, Mov Disord, 20, 592, 10.1002/mds.20376